<p>Advantages of metoprolol succinate in patients with chronic heart failure (CHF) are covered. Results of MERIT-HF study are taken as the main evidences. Patterns of the metoprolol succinate use in the treatment of different categories of patients with CHF (women, the elderly , severe CHF forms, CHF with concomitant hypertension or diabetes) are considered.</p
Prognosis remains poor for patients with chronic heartfailure (CHF), despite improvements in the pre...
Optimal treatment of heart failure is important to reduce hospitalization and mortality. In accordin...
<p>There were presented results of clinical trials on β-adrenoblockers usage in patients with chroni...
BACKGROUND Metoprolol has beneficial effects in congestive heart failure, it binds with beta adrene...
Ovidio De Freitas, Oliver Lenz, Alessia Fornoni, Barry J MatersonDivision of Nephrology and Hyperten...
AIMS: Internationally, research indicates that pharmacotherapy for chronic heart failure (CHF) is su...
Three large randomized trials in advanced heart failure (RALES), in heart failure after myocardial i...
The incidence of heart failure is increasing, particularly in older patients. Clinical trials often ...
Despite significant advances in pharmacological and non-pharmacological therapy, epidemiological dat...
Rational and aims In recent years, guidelines for treatment of patients with chronic heart failure (...
INTRODUCTION: Heart failure (HF) is an important public health problem with an increasing prevalence...
Heart failure (HF) is a clinical syndrome characterized by dyspnoea, fatigue and fluid retention acc...
AbstractOBJECTIVESThis study analyzed the effect of the beta1-selective beta-blocker metoprolol succ...
Heart failure is a major health problem and its prevalence is growing, primarily as a consequence of...
The efficacy of statin therapy in patients with established chronic heart failure (CHF) is a subject...
Prognosis remains poor for patients with chronic heartfailure (CHF), despite improvements in the pre...
Optimal treatment of heart failure is important to reduce hospitalization and mortality. In accordin...
<p>There were presented results of clinical trials on β-adrenoblockers usage in patients with chroni...
BACKGROUND Metoprolol has beneficial effects in congestive heart failure, it binds with beta adrene...
Ovidio De Freitas, Oliver Lenz, Alessia Fornoni, Barry J MatersonDivision of Nephrology and Hyperten...
AIMS: Internationally, research indicates that pharmacotherapy for chronic heart failure (CHF) is su...
Three large randomized trials in advanced heart failure (RALES), in heart failure after myocardial i...
The incidence of heart failure is increasing, particularly in older patients. Clinical trials often ...
Despite significant advances in pharmacological and non-pharmacological therapy, epidemiological dat...
Rational and aims In recent years, guidelines for treatment of patients with chronic heart failure (...
INTRODUCTION: Heart failure (HF) is an important public health problem with an increasing prevalence...
Heart failure (HF) is a clinical syndrome characterized by dyspnoea, fatigue and fluid retention acc...
AbstractOBJECTIVESThis study analyzed the effect of the beta1-selective beta-blocker metoprolol succ...
Heart failure is a major health problem and its prevalence is growing, primarily as a consequence of...
The efficacy of statin therapy in patients with established chronic heart failure (CHF) is a subject...
Prognosis remains poor for patients with chronic heartfailure (CHF), despite improvements in the pre...
Optimal treatment of heart failure is important to reduce hospitalization and mortality. In accordin...
<p>There were presented results of clinical trials on β-adrenoblockers usage in patients with chroni...